| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78941ed5a01bfbcd48376e1fdb485b19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0913ea2f28cf4ed41a1f64cec032b06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5783554a6c7cd46a5583b1c99e10a058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a16887c0091600b2a35a22251e9168e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acec6d48732733bbe92cf7fa1bed106d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f59aed4a19e1cae372c808b962b4bd8 |
| publicationDate |
2014-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014356414-A1 |
| titleOfInvention |
Targeted Crosslinked Multilamellar Liposomes |
| abstract |
A liposome composition that is useful for treating a subject in need of cancer treatment includes a cross-linked multilamellar liposome having an exterior surface and an interior surface. The interior surface defines a central liposomal cavity. The multilamellar liposome includes at least a first lipid bilayer and a second lipid bilayer. The first lipid bilayer is covalently bonded to the second lipid bilayer. At least one anticancer compound is disposed within the multilamellar liposome. Methods for treating subjects are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10864161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940112-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020264016-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021183318-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107021998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018175473-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023141540-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7061134-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10307491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023077118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021154140-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11041172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4256951-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110446489-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018021453-A1 |
| priorityDate |
2013-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |